| 000 | 01072nab a22002537a 4500 | ||
|---|---|---|---|
| 003 | PILC | ||
| 005 | 20221123181941.0 | ||
| 008 | 150723s9999 xx 000 0 und d | ||
| 022 | _a0002-936X | ||
| 040 | _cMANILA TYTANA COLLEGES LIBRARY | ||
| 100 | _aAschenbrenner, Diane S. | ||
| 245 | 0 | 0 |
_aNew treatment for opioid-induced constipation / _cDiane S. Aschenbrenner |
| 260 | _cJanuary 2015 | ||
| 440 |
_aAmerican Journal of Nursing _n115 : 1, page 23 |
||
| 520 | _aAn opioid antagonist, naloxegol (Movantik), has now been approved to treat opioid-induced constipation in adults with chronic noncancer pain. Naloxegol binds to mu-opiate receptors in the gastrointestinal tract, preventing opioids from attaching to them, which prevents the gastrointestinal slowing and constipation that typically occur with opioid use. | ||
| 521 | _aNursing | ||
| 650 | _aPharmaceutical industry. | ||
| 650 | _aNarcotic antagonists. | ||
| 650 | _aProduct development. | ||
| 650 | _aConstipation. | ||
| 650 | _aPain management. | ||
| 942 |
_cA _2lcc |
||
| 998 |
_c71644 _d130007 |
||
| 999 |
_c70073 _d70073 |
||